GOAL Clinical Trial

Osteoarthritis (OA) is the most common form of arthritis, affecting over 30 million Europeans. Patients with painful knee OA are often unable to perform their normal daily activities.

The GOAL Clinical Study will provide additional information about the KineSpring System, a medical device intended to relieve pain and improve function for patients with knee osteoarthritis.

The GOAL Clinical Study is now fully enrolled and is no longer accepting additional patients.